Qinqin Xu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Patient Reported Outcomes

High Throughput

Binding Protein

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan P Mackay, Paul M Weinberger, John A Copland, Elahe Mahdavian, Qinqin Xu
YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site. Molecular cancer therapeutics 21 (6) (2022)